cyclosporine has been researched along with Myasthenia Gravis in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.17) | 18.7374 |
1990's | 9 (19.57) | 18.2507 |
2000's | 22 (47.83) | 29.6817 |
2010's | 14 (30.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakane, S | 1 |
Ayvaz, DC; Bayrakci, B; Kesici, S; Kuskonmaz, B; Sag, E; Tezcan, I; Uckan, D; Unal, S; Yalnızoglu, D | 1 |
Abrahams, A; Auret, J; Heckmann, JM; Prince, S | 1 |
Apostolski, SA; Basta, IZ; Lavrnić, DV; Nikolić, AV; Nikolić, DM | 1 |
Kishimoto, K; Matsuse, H; Nakayama, H; Oshio, T | 1 |
Yokoyama, K | 1 |
Li, KX; Shao, H; Shi, LW; Sun, CH; Yang, LP; Zhang, YT | 1 |
Hirano, T; Nakajima, K; Oka, K; Saito, T; Tanaka, S; Wakata, N | 1 |
Hakii, Y; Kishida, H; Kuroiwa, Y; Kurokawa, T; Nishiyama, T; Yamamoto, R | 1 |
Eguchi, K; Ida, H; Imanishi, D; Kawakami, A; Motomura, M; Nakamura, H; Okada, A; Yamasaki, S | 1 |
Nagane, Y; Suzuki, N; Suzuki, S; Utsugisawa, K | 4 |
Allen, JA; Jones, HR; Scala, S | 1 |
Hayashi, A; Inoue, M; Kadota, Y; Kusu, T; Okumura, M; Sawabata, N; Shiono, H; Tokunaga, T | 1 |
Abe, Y; Honda, E; Nagasawa, E; Ohno, H; Sada, E; Shiratsuchi, M; Takayanagi, R | 1 |
Baron, J; Lin, H; Penumalli, V; Rezania, K; Soliven, B; van Besien, K | 1 |
Fujita, K; Kaneko, S; Kusaka, H; Morita, J; Nakamura, S; Nakano, S; Shinde, A | 1 |
Gogovska, L; Grcevska, L; Ljapcev, R; Polenakovic, M; Popovska, M; Stojkovski, L | 1 |
Bartoccioni, E; Batocchi, AP; Evoli, A; Marino, M; Monaco, ML; Padua, L; Scuderi, F; Tonali, PA | 1 |
Araga, S; Ishiga, K; Kowa, H; Nakano, T; Nakashima, K; Sakuma, K; Suto, Y; Tajima, F | 1 |
Doi, T; Fukahara, K; Kotoh, K; Misaki, T; Suzuki, E | 1 |
Konishi, T; Nishizawa, T; Yoshida, S; Yoshida, Y | 1 |
Apostolski, S; Basta, I; Lavrnic, D; Pavlovic, S; Rakocevic-Stojanovic, V; Stevic, Z; Trikic, R; Vujic, A | 1 |
Armengol, M; Azem, J; Buera, M; Cervera, C; Fort, JM; López-Cano, M; Ponseti, JM; Vilallonga, R | 1 |
Aarli, JA; Cutter, GR; Jaretzki, A; Kaminski, HJ; Phillips, LH; Sanders, DB | 1 |
Fukushima, K; Gono, T; Ikeda, S; Kaneko, K; Mastuda, M; Mitsuhashi, S; Sato, T; Yazaki, M | 1 |
Fujishima, M; Fujishima, N; Hirokawa, M; Sawada, K; Toyoshima, I; Wada, C; Watanabe, S | 1 |
Chambers, B; Donnan, G; Ierino, FL; Lim, AK | 1 |
Blesa, R; Dalmau, J; Díaz-Manera, J; Gallardo, E; Illa, I; Juárez, C; Martínez-Domeño, A; Martínez-Ramírez, S; Rojas-García, R | 1 |
Halim, AG; Hamidon, BB; Hamizah, R; Kong, NC; Norlinah, MI; Raymond, AA; Rohana, AG; Soehardy, Z; Tan, HJ | 1 |
Kakoulidou, M; Lefvert, AK; Pirskanen-Matell, R | 1 |
Hart, IK; Sathasivam, S; Sharshar, T | 1 |
Gondo, H; Harada, M; Nakamura, M; Niho, Y; Okamura, S; Otsuka, T; Sano, T; Shimoda, K | 1 |
Hall, K; Phillips, JT; Rollins, JA; Tindall, RS; Wells, L | 1 |
Lopate, G; Pestronk, A | 1 |
Batocchi, AP; Evoli, A; Tonali, P | 1 |
Angelini, C; Bonifati, DM | 1 |
Badia, P; Gil, R; Giraud, C; Hauet, T; Pourrat, O; Robert, R | 1 |
Aoyama, K; Kobayashi, S; Murakawa, Y; Okada, K; Takahashi, K; Umegae, N | 1 |
Meriggioli, MN; Rowin, J | 1 |
Ciafaloni, E; Massey, JM; Nikhar, NK; Sanders, DB | 1 |
Breathnach, A; Hutchinson, M; Keogh, JA; O'Reilly, S; Reilly, M; Walshe, E | 1 |
Tindall, RS | 1 |
Gunn, HC; Hanglow, AC; Hiestand, PC | 1 |
8 review(s) available for cyclosporine and Myasthenia Gravis
Article | Year |
---|---|
[Current concept and perspective of immunotherapy for myasthenia gravis: tacrolimus and cyclosporin].
Topics: Child; Cyclosporine; Female; Humans; Immunosuppressive Agents; Myasthenia Gravis; Pregnancy; Tacrolimus | 2008 |
Biological implications of thymectomy for myasthenia gravis.
Topics: Adult; Age Factors; Autoantibodies; B-Lymphocytes; Cyclosporine; Humans; Immunosuppressive Agents; Myasthenia Gravis; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Receptors, Nicotinic; T-Lymphocytes; Tacrolimus; Thymectomy; Thymoma; Thymus Gland | 2010 |
[Successful treatment with immunosuppressive therapy for aplastic anemia developed after resection of thymoma].
Topics: Anemia, Aplastic; Autoantibodies; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Middle Aged; Myasthenia Gravis; Postoperative Complications; Thymectomy; Thymoma; Thymus Neoplasms; Time Factors; Treatment Outcome | 2011 |
Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature.
Topics: 2-Chloroadenosine; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Deoxyadenosines; Fatal Outcome; Female; Humans; Lymphoma; Lymphoma, Follicular; Lymphoproliferative Disorders; Male; Middle Aged; Myasthenia Gravis; Paraneoplastic Syndromes, Nervous System; Prednisone; Pyridostigmine Bromide; Recurrence; Remission Induction; Rituximab; Waldenstrom Macroglobulinemia | 2012 |
Immunosuppressive agents for myasthenia gravis.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Myasthenia Gravis; Mycophenolic Acid; Prednisolone; Randomized Controlled Trials as Topic; Tacrolimus | 2007 |
Autoimmune myasthenia gravis.
Topics: Adult; Age Factors; Antibody Formation; Autoimmune Diseases; Cyclosporine; Diagnosis, Differential; Humans; Immunoglobulins, Intravenous; Infant, Newborn; Male; Myasthenia Gravis; Neuromuscular Junction; Plasmapheresis; Prednisone; Pyridostigmine Bromide; Receptors, Cholinergic; Synaptic Transmission; Thymectomy; Thymus Gland | 1993 |
A practical guide to the recognition and management of myasthenia gravis.
Topics: Adrenal Cortex Hormones; Azathioprine; Cholinesterase Inhibitors; Cyclosporine; Diagnosis, Differential; Humans; Myasthenia Gravis; Thymectomy | 1996 |
Immunointervention with cyclosporin A in autoimmune neurological disorders.
Topics: Acrodynia; Amyotrophic Lateral Sclerosis; Autoimmune Diseases; Cyclosporine; Demyelinating Diseases; Humans; Multiple Sclerosis; Myasthenia Gravis; Myositis; Nervous System Diseases; Polyradiculoneuropathy | 1992 |
5 trial(s) available for cyclosporine and Myasthenia Gravis
Article | Year |
---|---|
Two-year treatment with cyclosporine microemulsion for responder myasthenia gravis patients.
Topics: Adult; Aged; Chi-Square Distribution; Cyclosporine; Emulsions; Female; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Middle Aged; Myasthenia Gravis; Severity of Illness Index; Statistics, Nonparametric; Time Factors | 2010 |
Cyclosporine in the treatment of myasthenia gravis.
Topics: Adult; Cyclosporine; Disabled Persons; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myasthenia Gravis; Severity of Illness Index; Treatment Outcome | 2005 |
Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Ataxia; Autoantibodies; Cyclosporine; Dizziness; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Muscle Weakness; Myasthenia Gravis; Prednisone; Prospective Studies; Receptors, Cholinergic; Remission Induction; Renal Insufficiency; Tacrolimus; Thymectomy; Time; Treatment Outcome | 2005 |
A clinical therapeutic trial of cyclosporine in myasthenia gravis.
Topics: Adult; Aged; Autoantibodies; Cyclosporine; Double-Blind Method; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Prednisone; Receptors, Nicotinic | 1993 |
Long-term cyclosporine treatment in a group of severe myasthenia gravis patients.
Topics: Adolescent; Adult; Cost-Benefit Analysis; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myasthenia Gravis; Time Factors; Treatment Outcome | 1997 |
33 other study(ies) available for cyclosporine and Myasthenia Gravis
Article | Year |
---|---|
[Calcineurin inhibitors and IVIg in the treatment of myasthenia gravis].
Topics: Calcineurin Inhibitors; Cyclosporine; Immunoglobulins, Intravenous; Japan; Myasthenia Gravis; Prednisolone; Registries; Severity of Illness Index; Tacrolimus; Treatment Outcome | 2013 |
Successful treatment of severe myasthenia gravis developed after allogeneic hematopoietic stem cell transplantation with plasma exchange and rituximab.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Hearing Loss, Sensorineural; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Myasthenia Gravis; Mycophenolic Acid; Piebaldism; Pigmentation Disorders; Plasma Exchange; Remission Induction; Rituximab; Transplantation, Homologous; Treatment Outcome | 2014 |
The effects of prednisone and steroid-sparing agents on decay accelerating factor (CD55) expression: implications in myasthenia gravis.
Topics: Animals; Azathioprine; CD55 Antigens; Cell Line; Chlorocebus aethiops; COS Cells; Cyclosporine; Glucocorticoids; Humans; Methotrexate; Mice; Myasthenia Gravis; Prednisone | 2014 |
A misdiagnosed myasthenia gravis with anti-muscle-specific tyrosine kinase antibodies with possible childhood onset.
Topics: Autoantibodies; Biomarkers; Cyclosporine; Diagnostic Errors; Female; Humans; Immunosuppressive Agents; Miller Fisher Syndrome; Muscle, Skeletal; Myasthenia Gravis; Predictive Value of Tests; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Recurrence; Treatment Outcome; Young Adult | 2015 |
[A CASE OF PULMONARY MYCOBACTERIUM ABSCESSUS INFECTION THAT DEVELOPED DURING IMMUNOSUPPRESSIVE THERAPY FOR MYASTHENIA GRAVIS WITH RECURRENT THYMOMA].
Topics: Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Levofloxacin; Male; Middle Aged; Myasthenia Gravis; Mycobacterium Infections, Nontuberculous; Neoplasm Recurrence, Local; Thymoma; Thymus Neoplasms; Treatment Outcome | 2016 |
ABCB1 polymorphisms may have a minor effect on ciclosporin blood concentrations in myasthenia gravis patients.
Topics: Adolescent; Adult; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Exons; Female; Genes, MDR; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Immunosuppressive Agents; Male; Middle Aged; Myasthenia Gravis; Polymorphism, Single Nucleotide; Predictive Value of Tests | 2008 |
Suppressive potencies of calcineurin inhibitors against the mitogen-induced blastogenesis of peripheral-blood mononuclear cells of myasthenia gravis patients.
Topics: Adult; Calcineurin Inhibitors; Concanavalin A; Cyclosporine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Inhibitory Concentration 50; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Mitogens; Myasthenia Gravis; Tacrolimus | 2008 |
[Anti-MuSK antibody positive myasthenia gravis with HIV infection successfully treated with cyclosporin: a case report].
Topics: Autoantibodies; Cyclosporine; HIV Infections; Humans; Immunosuppressive Agents; Male; Middle Aged; Myasthenia Gravis; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Treatment Outcome | 2008 |
Isoniazid-triggered pure red cell aplasia in systemic lupus erythematosus complicated with myasthenia gravis.
Topics: Antitubercular Agents; Cyclosporine; Drug Therapy, Combination; Erythroblasts; Female; Humans; Immunosuppressive Agents; Iron; Isoniazid; Lupus Erythematosus, Systemic; Middle Aged; Myasthenia Gravis; Red-Cell Aplasia, Pure; Reticulocyte Count; Reticulocytes; Treatment Outcome | 2010 |
Factors associated with response to calcineurin inhibitors in myasthenia gravis.
Topics: Adult; Aged; Autoantibodies; Calcineurin Inhibitors; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Immunotherapy; Kv1.4 Potassium Channel; Logistic Models; Male; Middle Aged; Myasthenia Gravis; Retrospective Studies; Severity of Illness Index; Tacrolimus; Thymoma; Treatment Outcome | 2010 |
Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosis.
Topics: Age Factors; Age of Onset; Aged; Aged, 80 and over; Azathioprine; Chi-Square Distribution; Cyclosporine; Disease Progression; Disease-Free Survival; Electric Stimulation; Electromyography; Female; Humans; Immunotherapy; Male; Myasthenia Gravis; Patient Selection; Plasma Exchange; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Severity of Illness Index; Thymectomy; Treatment Outcome | 2010 |
[Directions for use of corticosteroids and calcineurin inhibitors against generalized myasthenia gravis: therapeutic strategies that can lead to early improvements and veer away from high-dose oral corticosteroids].
Topics: Calcineurin Inhibitors; Cyclosporine; Emulsions; Humans; Myasthenia Gravis; Prednisolone; Quality of Life; Tacrolimus | 2012 |
Prednisolone-sparing effect of cyclosporin A therapy for very elderly patients with myasthenia gravis.
Topics: Aged, 80 and over; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperglycemia; Hypertension; Immunosuppressive Agents; Myasthenia Gravis; Prednisolone; Treatment Outcome | 2013 |
Plasmaexchange in the treatment of myasthenia gravis associated with thymoma.
Topics: Adult; Azathioprine; Cholinesterase Inhibitors; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Methylprednisolone; Myasthenia Gravis; Plasma Exchange; Remission Induction; Thymectomy; Thymoma | 2003 |
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Topics: Adolescent; Adult; Age of Onset; Aged; Autoantibodies; Azathioprine; Case-Control Studies; Child; Cyclosporine; Electromyography; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Myasthenia Gravis; Plasma Exchange; Prednisone; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Sex Distribution; Thymectomy; Thymus Gland | 2003 |
Myasthenia gravis with thymus hyperplasia and pure red cell aplasia.
Topics: Cyclosporine; Female; Humans; Immunosuppressive Agents; Middle Aged; Myasthenia Gravis; Red-Cell Aplasia, Pure; Thymectomy; Thymus Hyperplasia | 2004 |
[A constrictive pericarditis on oral steroid and immunosuppressant treated with bilateral anterolateral thoracotomy; report of a case].
Topics: Anti-Inflammatory Agents; Cyclosporine; Humans; Immunosuppressive Agents; Male; Methenolone; Middle Aged; Myasthenia Gravis; Pericardiectomy; Pericarditis, Constrictive; Prednisolone; Red-Cell Aplasia, Pure; Thymoma; Thymus Neoplasms | 2004 |
Effect of tacrolimus in a patient with pure red-cell aplasia.
Topics: Aged; Anemia; Cyclosporine; Disease Progression; Erythrocyte Transfusion; Female; Humans; Kidney; Myasthenia Gravis; Red-Cell Aplasia, Pure; Remission Induction; Tacrolimus; Thymoma | 2005 |
Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
Topics: Cohort Studies; Cyclosporine; Humans; Myasthenia Gravis; Prednisone; Research Design; Tacrolimus; Time | 2006 |
Pure red cell aplasia developing after treatment of pleural recurrence of thymoma, successfully treated with cyclosporin A but not with tacrolimus.
Topics: Adult; Cyclosporine; Humans; Immunosuppressive Agents; Male; Myasthenia Gravis; Pleural Neoplasms; Red-Cell Aplasia, Pure; Tacrolimus; Thymectomy; Thymoma; Thymus Neoplasms | 2006 |
Oligoclonal T cell expansion in blood but not in the thymus from a patient with thymoma-associated pure red cell aplasia.
Topics: Clone Cells; Cyclosporine; Female; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Humans; Immunosuppressive Agents; Middle Aged; Myasthenia Gravis; Prednisolone; Red-Cell Aplasia, Pure; T-Lymphocyte Subsets; Tacrolimus; Thymectomy; Thymoma; Thymus Neoplasms | 2006 |
Mycophenolate mofetil substitution for cyclosporine-dependent myasthenia gravis and nephrotoxicity.
Topics: Adult; Cyclosporine; Diabetic Nephropathies; Drug Evaluation; Female; Humans; Hypertension, Renal; Immunosuppressive Agents; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Myasthenia Gravis; Mycophenolic Acid; Plasma Exchange; Prednisolone; Recurrence; Thymectomy | 2007 |
Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Cyclosporine; Diagnosis, Differential; Female; Humans; Immunoglobulins, Intravenous; Immunohistochemistry; Immunologic Factors; Middle Aged; Muscle Weakness; Muscular Atrophy; Myasthenia Gravis; Myokymia; Nervous System Diseases; Personality Disorders; Potassium Channels, Voltage-Gated; Prednisone; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Respiratory Insufficiency; Rituximab | 2007 |
Case of severe refractory myasthenia gravis in HUKM.
Topics: Adult; Cyclosporine; Female; Humans; Immunoglobulins; Immunosuppressive Agents; Myasthenia Gravis; Mycophenolic Acid; Plasmapheresis; Prednisolone; Thymectomy | 2006 |
Treatment of a patient with myasthenia gravis using antibodies against CD25.
Topics: Adult; Antibodies, Monoclonal; Antigens, Surface; Basiliximab; Cyclosporine; Cytokines; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Interleukin-2 Receptor alpha Subunit; Muscle Fatigue; Myasthenia Gravis; Prednisone; Recombinant Fusion Proteins | 2008 |
Monitoring treatment with cyclosporine microemulsion in myasthenia gravis.
Topics: Body Mass Index; Cyclosporine; Drug Monitoring; Emulsions; Female; Hematologic Tests; Humans; Immunosuppressive Agents; Male; Middle Aged; Myasthenia Gravis | 2008 |
Myasthenia gravis after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Graft vs Host Disease; HLA-B7 Antigen; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Myasthenia Gravis; Prednisolone; Transplantation, Homologous | 1994 |
Are long-term plasma exchanges and ciclosporin useful in the management of severe chronic respiratory failure due to myasthenia gravis?
Topics: Aged; Chronic Disease; Combined Modality Therapy; Cyclosporine; Female; Humans; Immunosuppressive Agents; Myasthenia Gravis; Plasma Exchange; Respiratory Insufficiency; Time Factors | 1997 |
[A case of cyclosporin responsive myasthenia gravis with an invasive thymoma].
Topics: Adult; Combined Modality Therapy; Cyclosporine; Female; Humans; Immunosuppressive Agents; Myasthenia Gravis; Thymoma; Thymus Neoplasms; Treatment Outcome | 1998 |
Treatment of myasthenia gravis with mycophenolate mofetil: a case report.
Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Myasthenia Gravis; Mycophenolic Acid; Prednisolone | 2000 |
Retrospective analysis of the use of cyclosporine in myasthenia gravis.
Topics: Adult; Aged; Aged, 80 and over; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myasthenia Gravis; Retrospective Studies | 2000 |
Myasthenia gravis associated with cyclosporin treatment.
Topics: Cyclosporine; Female; Humans; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Myasthenia Gravis | 1992 |
Ciclosporin treatment in experimental autoimmune myasthenia gravis.
Topics: Animals; Autoantibodies; Cyclosporine; Cyclosporins; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Myasthenia Gravis; Rats; Rats, Inbred BB; Rats, Inbred Lew | 1988 |